Neonatal screening for lysosomal storage disorders

The Lancet

Volumn 379, Issue 9813, 2012, Pages 294-295

  Fletcher, Janice ^a,b   Wilcken, Bridget ^c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRIA; ENZYME ANALYSIS; FABRY DISEASE; GAUCHER DISEASE; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; LYSOSOME STORAGE DISEASE; NEWBORN SCREENING; NIEMANN PICK DISEASE; NOTE; PHENOTYPE; PRIORITY JOURNAL;

EID: 84856382616     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61744-3     Document Type: Note

References (13)

1. K Nakamura, K Hattori, F Endo Newborn screening for lysosomal storage disorders Am J Med Genet C Semin Med Genet 157 2011 63 71
2. YH Chien, NC Lee, BL Thurberg et al. Pompe disease in infants: improving the prognosis by newborn screening and early treatment Pediatrics 124 2009 e1116 e1125
3. TP Mechtler, S Stary, TF Metz et al. Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria Lancet 2011 10.1016/S0140-6736(11)61266-X published online Nov 30.
4. M Spada, S Pagliardini, M Yasuda et al. High incidence of later-onset Fabry disease revealed by newborn screening Am J Hum Genet 79 2006 31 40 (Pubitemid 43927374)
5. WL Hwu, YH Chien, NC Lee et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) Hum Mutat 30 2009 1397 1405
6. RJ Pollitt Introducing new screens: why are we all doing different things? J Inherit Metab Dis 30 2007 423 429 (Pubitemid 47377037)
7. N Calonge, NS Green, P Rinaldo et al. Committee report: method for evaluating conditions nominated for population-based screening of newborns and children. Advisory Committee on Heritable Disorders in Newborns and Children Genet Med 12 2010 153 159
8. UK National Screening Committee Programme appraisal criteria http://www.screening.nhs.uk/criteria (accessed Nov 5, 2011).
9. PM Farrell, HJ Lai, Z Li et al. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr 147 suppl 3 2005 S30 S36
10. B Wilcken, M Haas, P Joy et al. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years Pediatrics 124 2009 e241 e248
11. LA Prosser, JA Ladapo, D Rusinak, SE Waisbren Parental tolerance of false-positive newborn screening results Arch Pediatr Adolesc Med 162 2008 870 876
12. M Connock, A Burls, E Frew et al. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review Health Technol Assess 10 2006 1 136
13. IM Hayes, V Collins, M Sahhar, JE Wraith, MB Delatycki Newborn screening for mucopolysaccharidoses: opinions of patients and their families Clin Genet 71 2007 446 450 (Pubitemid 46730654)